Reports claim the BA.2 has overtaken the BA.1 subvariant in Denmark, although early assessment by scientists showed the effectiveness of the vaccine does not decrease in BA.2.
Reports claim the BA.2 has overtaken the BA.1 subvariant in Denmark, although early assessment by scientists showed the effectiveness of the vaccine does not decrease in BA.2.